Groprinosin-Richter (inosine pranobex) syrup

Groprinosin-Richter (inosine pranobex) syrup

SKU:2637
To favorites
Groprinosin-Richter (inosine pranobex) syrup
Active substance:inosine pranobex
Pharmacological group:Antiviral
Formulation:Syrup
Dosage mg:50
In stock
$33
11
Description
Features
Reviews

Instructions for Groprinosin-Richter (inosine pranobex) syrup

Form of release, packaging and composition of the drug Groprishin®-Richter
Syrup in the form of a clear yellowish liquid. 1 ml
inosine pranobex 50 mg

Auxiliary substances Groprinosin-Richter:
methylparahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sucrose, sodium hydroxide (E524), citric acid monohydrate, water.
150 ml - vials light-proof from hydrolytically stable (III class) glass (1) complete with a syringe of plastic low-density polyethylene, graded from 0.5 ml to 5 ml - packs of cardboard.
Clinical-pharmacological group: Immunostimulating drug with antiviral activity

Pharmacotherapeutic group Groprinosin-Richter:

Systemic antiviral agents; direct-acting antiviral agents; other antiviral agents

Dosing mode Groprinosin-Richter

Inside after a meal, drinking a small amount of water, at equal intervals (eight or six hours) three - four times a day.
For the correct dosage, a measuring syringe is attached to take the drug by mouth.
Adults and children over twelve years of age
Twenty ml of syrup three to four times a day. The maximum daily dose is eighty ml.
Treatment for influenza and other SARSs lasts from five to fourteen days. The drug should be continued for one to two days after symptoms resolve.

Indications of the drug Groprisnin®-Richter

Treatment of influenza and other acute respiratory viral infections (SARS) as a part of complex therapy;
treatment of labial herpes (Herpes simplex) as part of complex therapy.

  • ICD-10 Groprinosin-Richter Code
  • B00 Herpes virus infections [herpes simplex]
  • B34.9 Viral infection, unspecified
  • J00 Acute nasopharyngitis (runny nose)
  • J01 Acute sinusitis
  • J02 Acute pharyngitis
  • J02.9 Acute pharyngitis, unspecified
  • J03 Tonsillitis acute
  • J04 Acute laryngitis and tracheitis
  • J04.1 Acute tracheitis
  • J04.2 Acute laryngotracheitis
  • J06 Acute upper respiratory infections of multiple and unspecified sites
  • J06.0 Acute laryngopharyngitis
  • J06.9 Acute upper respiratory infection, unspecified
  • J10 Influenza due to identified seasonal influenza virus
  • J11 Influenza, unspecified
  • J20 Acute bronchitis
  • J21 Acute bronchiolitis
  • J22 Acute respiratory infection of lower respiratory tract, unspecified
Features
Active substance
Pharmacological group
Formulation
Dosage mg
Pills in 1 package
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating
Analogues
Isoprinosine (inosine pranobex)
SKU:2638
$36
In stock
Groprinosin (inosine pranobex)
SKU:2633
$37
In stock
Normomed (Inosine pranobex)
SKU:2185
$34
In stock